NCT00341250View on ClinicalTrials.gov

Malaria Vaccine in Children in Mali

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

January 19, 2006

Study Completion Date

December 8, 2006

Conditions
Malaria
Interventions
DRUG

AMA1-C1/Alhydrogel Malaria Vaccine

Trial Locations (2)

Unknown

Bancoumana Clinical Trial Center, Bankoumana

Doneguebougou Malaria Vaccine Center, Donéguébougou

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00341250 - Malaria Vaccine in Children in Mali | Biotech Hunter | Biotech Hunter